Fatigue and Kampo (Japanese Herbal) Medicines: Hochuekkito and Juzentaihoto

  • Jun-ichi YamakawaEmail author
  • Junji Moriya
  • Junji Kobayashi
Part of the Methods in Pharmacology and Toxicology book series (MIPT)


Together with pain and fever, fatigue is known as one of the living body’s three main alarms, an important signal to the body for the maintenance of life and health. The body usually recovers from fatigue with rest, but a feeling of fatigue may persist for a long period. When the symptoms and duration of fatigue exceed the usual fatigued feeling, the body’s immune function deteriorates making it prone to psychological disorders such as depression, as well as a range of infectious diseases. Few Western medications are useful for this kind of fatigue. There are, however, many useful formulae among Kampo medications. The introduction below first gives a brief explanation of qi (Ki), blood and fluid (Kiketsusui), and the “patterns” of Kampo medical diagnosis before discussing the Kampo medical diagnoses “qi (Ki) deficiency (Kikyo), blood deficiency (Kekkyo), and dual deficiency of qi (Ki) and blood (Kiketsu Ryokyo)” and how fatigue was perceived in olden times. The “Discussion” part focuses on clinical reports on two prominent Kampo medications, hochuekkito (補中益気湯) and juzentaihoto (十全大補湯).

Key words

Fatigue Kampo Hochuekkito Juzentaihoto qi (Ki) deficiency (KikyoDual deficiency of qi (Ki) Blood (Kiketsu Ryokyo


  1. 1.
    Yamakawa J (2012) Efficacy evaluation of kampo medicine in a mouse model of chronic fatigue syndrome. In: Motoo Y (ed) Traditional medicine new research. Nova Science Publishers, Inc, New York, pp 83–122Google Scholar
  2. 2.
    Chen R, Moriya J, Yamakawa J et al (2010) Traditional Chinese medicine for chronic fatigue syndrome. Evid Based Complement Alternat Med 7:3–10CrossRefPubMedGoogle Scholar
  3. 3.
    Otsuka K, Otsuka Y, Watanabe K (2000) Practical symptom-based kampo therapy (Revised), 5th edn. Nanzando, Tokyo, pp 231–232Google Scholar
  4. 4.
    Matsuda K (1992) Practice of kampo treatment – diagnosis and treatment, 74(11). Shindan To Chiryo Sha Inc, Osaka, pp 2278–2282Google Scholar
  5. 5.
    Tatsuno K (1979) An outline of kampo medicine 1 (1). Yukonsha, Kyoto, pp 12–14Google Scholar
  6. 6.
    Terasawa K (2005) Kampo patterns (Sho): a patient-centered, not disease-centered, diagnostic system. Kagaku 75. Iwanami Shoten Publishers, Tokyo, pp 821–823Google Scholar
  7. 7.
    Matsuda K (1980) “Yoshimasu Nangai”, an exposition of his compendium, vol 37. Meicho Shuppan, Osaka, p 16Google Scholar
  8. 8.
    Yoshimasu N Medical Patterns – Modern Kampo Medicine Compendium vol 37 p 134Google Scholar
  9. 9.
    Terasawa K (2006) On the formation of Chinese great classic “shokanron”, and its specificity. Kampo Med 57:799–804CrossRefGoogle Scholar
  10. 10.
    The Japan Kampo Medicine Association – Academic Committee (2000) Shanhan Zabinglun (Treatise on Cold Damage Disorders), 3rd edn. Toyo Gakujutsu Shuppansha, ChibaGoogle Scholar
  11. 11.
    Mayanagi M (1989) A bibliographical introduction to Neiwaishangbianhuolun (Treatise on clarification of perplexities about internal and external damage), Piweilun (Treatise on the spleen and stomach), and Lanshimicang (Secret records of the orchid chamber), Kosoto H, Mayanagi M (eds). Wakoku Kanseki Isho Shusei vol 6 Commentary. Enterprise, Tokyo, p 22–36Google Scholar
  12. 12.
    Mayanagi M, Kosoto H (1990) Medical texts in Jin period. J Tradit Sino-Jpn Med 11:495–501Google Scholar
  13. 13.
    Mayanagi M (1995) The history of a Chinese herbal prescription Bu-Zhong-Yi-Qi-Tang. J Tradit Sino-Jpn Med 16:501–507Google Scholar
  14. 14.
    Yamakawa J, Motoo Y, Moriya J et al (2013) Role of kampo medicine in integrative cancer therapy. Evid Based Complement Alternat Med 2013:570848PubMedPubMedCentralGoogle Scholar
  15. 15.
    Yamakawa J, Motoo Y, Moriya J et al (2013) Significance of Kampo, traditional Japanese medicine, in supportive care of cancer patients. Evid Based Complement Alternat Med 2013:746486PubMedPubMedCentralGoogle Scholar
  16. 16.
    Yamakawa J, Moriya J, Takeuchi K et al (2013) Significance of Kampo, Japanese traditional medicine, in the treatment of obesity: basic and clinical evidence. Evid Based Complement Alternat Med 2013:943075PubMedPubMedCentralGoogle Scholar
  17. 17.
    Yamakawa J, Moriya J, Takahashi T et al (2010) A Kampo medicine, Boi-ogi-to, inhibits obesity in ovariectomized rats. Evid Based Complement Alternat Med 7:87–95CrossRefPubMedGoogle Scholar
  18. 18.
    Abe K (1989) The effects of hochuekkito for side effects of chemotherapy after cancer surgery. Prog Med 9:2916–2922Google Scholar
  19. 19.
    Ohara T, Onda M, Futagawa S et al (1993) Study of the usefulness of combining hochuekkito and ninjinyoeito with Tegafur. Jpn Pharmacol Ther 21:4423–4434Google Scholar
  20. 20.
    Ohno S (1988) Effects of a traditional Chinese medicine “hochuekki-to” on natural killer activity. Arerugi 37:107–114Google Scholar
  21. 21.
    Watanabe A, Hasegawa S (1992) Effect of combined Kampo medicines as adjuvant therapy for pulmonary tuberculosis. Jpn Med J 3553:76–77Google Scholar
  22. 22.
    Suzuki J, Arata S, Sugiyama M (2002) Improvement of immunity and nutrition by hochuekkito in immune-compromised hosts–for the control of MRSA. Prog Med 22:1362–1363Google Scholar
  23. 23.
    Irie K, Tateishi M, Yuu H et al (1992) Clinical effects of hochuekkito on gastroptosis symptoms. J N Remedies Clin 41:423–432Google Scholar
  24. 24.
    Tomita H, Chiba S, Kadowaki J et al (1997) Clinical effects of hochuekkito on pediatric orthostatic disturbance. J Pediatr Pract 60:162–167Google Scholar
  25. 25.
    Kuratsune H, Yamaguchi K, Tokumine Y (1997) Kampo formulations for chronic fatigue syndrome–clinical effects of hochuekkito. Jpn J Clin Exp Med 74:1837–1845Google Scholar
  26. 26.
    Kuratsune H, Nakatomi Y, Kagura M et al (2010) Clinical effectiveness of twice daily hochuekkito for chronic fatigue syndrome patients. Prog Med 30:505–510Google Scholar
  27. 27.
    Moriya J (2006) Establishment of murine model for chronic fatigue syndrome and efficacy of kampo medicine on daily activity. J Kanazawa Med Univ 31:263–268Google Scholar
  28. 28.
    Chen R, Moriya J, Yamakawa J et al (2008) Brain atrophy in a murine model of chronic fatigue syndrome and beneficial effect of Hochu-ekki-to (TJ-41). Neurochem Res 33:1759–1767CrossRefPubMedGoogle Scholar
  29. 29.
    Matsuzawa K, Nakano H, Oonishi Y (1997) Effects of hochuekkito for sleep-disordered breathing―a preliminary study using pulse oximetry. Jpn J Chest Dis 56:846–849Google Scholar
  30. 30.
    Ping L, Takase K, Mukobayashi M et al (1996) Clinical effects of traditional Chinese herbal medicine “Hochuekkito” on male infertility. Advances Obstet Gynecol 48:406–410Google Scholar
  31. 31.
    Ohara K, Nishimoto M, Miyazato K et al (1994) Effects of hochuekkito (TJ-41) for anorexia. Prog Med 14:1705–1712Google Scholar
  32. 32.
    Kurokawa T, Imai J, Tamakuma M (1989) Improvement of anorexia, nausea and vomiting, and lassitude, side effects of anti-cancer drug administration. “Effects of juzentaihoto in preventing anti-cancer drug side effects–A clinical immunology study”. Biotherapy 3:789–795Google Scholar
  33. 33.
    Suzuki S, Abe R, Nomizu T et al (1995) Effect of juzentaihoto (TJ-48) on leukopenia in patients receiving cancer chemotherapy. Prog Med 15:1968–1971Google Scholar
  34. 34.
    Niwa K, Hashimoto M, Tamaya T (2000) Effects of Juzen-taiho-to and M-CSF on thrombocytopenia induced by anti-cancer drugs in gynecologic malignancies. Jpn J Orient Med 51:447–454Google Scholar
  35. 35.
    Yamada T (1992) Clinical study of juzen-taiho-to administration for postoperative esophageal carcinoma, gastric carcinoma, and colorectal carcinoma – Influence of surgical intervention and postoperative chemotherapy on cell mediated immunity. J Med Pharm Soc WAKAN-YAKU 9:157–164Google Scholar
  36. 36.
    Rino Y, Yukawa N, Yamada R et al (2013) Improvement of adverse effects by juzen-taiho-to in the chemotherapy for patients with advanced or recurrent gastric cancer. J Jpn Coll Surg 38:62–66Google Scholar
  37. 37.
    Konno H, Maruo Y, Baba S et al (1997) Improvement of immunocompetence with combined use of juzendaihoto in adjuvant chemotherapy after gastric cancer surgery. Biotherapy 11:193–199Google Scholar
  38. 38.
    Kosaka A, Kamiya T, Sumiyama M et al (1994) Usefulness of TSUMURA Juzentaihoto (TJ-48) for reducing adverse effects of anticancer drugs and improving QOL. Prog Med 14:2259–2264Google Scholar
  39. 39.
    Adachi I (1990) Supporting therapy with Shi Quan Da Bu Tang in advanced breast cancer patients. Biomed Res 11:25–31Google Scholar
  40. 40.
    Tanaka Y, Hashimoto S (1988) Effects of TSUMURA Juzentaihoto on various complaints occurring as adverse reactions during radiotherapy. JAMA 6:70–71Google Scholar
  41. 41.
    Tarao K, Okamoto T, Miyakawa K et al (2003) Effect of Juzen-taiho-to on the serum alanine aminotransferase levels in patients with HCV-associated chronic hepatitis or liver cirrhosis. Jpn J Orient Med 54:191–198Google Scholar
  42. 42.
    Tarao K, Sakamoto Y, Ueno M et al (2010) Juzentaihoto (TJ-48) may be an important and effective anti-inflammatory agent for intractable cases of patients with HCV-associated chronic liver-diseases. Jpn J Orient Med 61:1–8Google Scholar
  43. 43.
    Sho Y, Fujisaki K, Sakashita H et al (2004) Orally administered Kampo medicine, Juzen-taiho-to, ameliorates anemia during interferon plus ribavirin therapy in patients with chronic hepatitis C. J Gastroenterol 39:1202–1204CrossRefPubMedGoogle Scholar
  44. 44.
    Higuchi K, Shimizu Y, Yasumura S et al (2002) Preventive effect of liver carcinogenesis by juzen-taiho-to in the patients with liver cirrhosis. Kan-Tan-Sui 44:341–346Google Scholar
  45. 45.
    Aoe H, Ota M, Kawahara N et al (2003) Efficacy of using juzentaihoto to augment preoperative autologous blood donation. J Med Technol 47:395–399Google Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • Jun-ichi Yamakawa
    • 1
    Email author
  • Junji Moriya
    • 1
  • Junji Kobayashi
    • 1
  1. 1.Department of General MedicineKanazawa Medical UniversityUchinadaJapan

Personalised recommendations